Transmembrane Prostatic Acid Phosphatase (TMPAP) Interacts with Snapin and Deficient Mice Develop Prostate Adenocarcinoma

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Quintero, Ileana B ^a   Herrala, Annakaisa M ^a   Araujo, César L ^a   Pulkka, Anitta E ^a   Hautaniemi, Sampsa ^b   Ovaska, Kristian ^b   Pryazhnikov, Evgeny ^b   Kulesskiy, Evgeny ^b   Ruuth, Maija K ^a   Soini, Ylermi ^c   Sormunen, Raija T ^d   Khirug, Leonard ^b   Vihko, Pirkko T ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

^d UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE PROSTATE ISOENZYME; PROTEIN SNAPIN; SNARE PROTEIN; TRANSMEMBRANE PROSTATIC ACID PHOSPHATASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CELL COUNT; CELL INVASION; CELL POLARITY; CONTROLLED STUDY; CPLX1 GENE; EPITHELIUM CELL; EXOCYTOSIS; EXOSOME; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE EXPRESSION; GENOTYPE; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE; PATHOGENESIS; PROSTATE ADENOCARCINOMA; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RAT; SNAP25 GENE; SYT1 GENE; SYT4 GENE;

ADENOCARCINOMA; ANIMALS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; MALE; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; PROSTATE; PROSTATIC NEOPLASMS; PROTEIN BINDING; PROTEIN TRANSPORT; PROTEIN TYROSINE PHOSPHATASES; PSEUDOPODIA; VESICULAR TRANSPORT PROTEINS;

EID: 84883780879     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0073072     Document Type: Article

References (51)

1. Gutman AB, Gutman EB, (1938) An "acid" phosphatase occurring in the serum of patients with metastasizing carcinoma of the prostate gland. J Clin Invest 17: 473-478 10.1172/JCI100974.
2. Kantoff PW, Higano CS, Shore ND, Berger ER, Small EJ, et al. (2010) Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N Engl J Med 363: 411-422 10.1056/NEJMoa1001294.
3. Hakalahti L, Vihko P, Henttu P, Autio-Harmainen H, Soini Y, et al. (1993) Evaluation of PAP and PSA gene expression in prostatic hyperplasia and prostatic carcinoma using northern-blot analyses, in situ hybridization and immunohistochemical stainings with monoclonal and bispecific antibodies. Int J Cancer 55: 590-597.
4. Lindqvist Y, Schneider G, Vihko P, (1993) Three-dimensional structure of rat acid phosphatase in complex with L (+)-tartrate. J Biol Chem 268: 20744-20746.
5. Quintero IB, Araujo CL, Pulkka AE, Wirkkala RS, Herrala AM, et al. (2007) Prostatic acid phosphatase is not a prostate specific target. Cancer Res 67: 6549-6554 --10.1158/0008-5472. CAN-07-1651.
6. Lin MF, DaVolio J, Garcia-Arenas R, (1992) Expression of human prostatic acid phosphatase activity and the growth of prostate carcinoma cells. Cancer Res 52: 4600-4607.
7. Chuang TD, Chen SJ, Lin FF, Veeramani S, Kumar S, et al. (2010) Human prostatic acid phosphatase, an authentic tyrosine phosphatase, dephosphorylates ErbB-2 and regulates prostate cancer cell growth. J Biol Chem 285: 23598-23606 10.1074/jbc. M109.098301.
8. Veeramani S, Chou YW, Lin FC, Muniyan S, Lin FF, et al. (2012) Reactive oxygen species induced by p66Shc longevity protein mediate nongenomic androgen action via tyrosine phosphorylation signaling to enhance tumorigenicity of prostate cancer cells. Free Radic Biol Med 53: 95-108 10.1016/j.freeradbiomed.2012.03.024.
9. de Gassart A, Geminard C, Fevrier B, Raposo G, Vidal M, (2003) Lipid raft-associated protein sorting in exosomes. Blood 102: 4336-4344 --10.1182/blood-2003-03-0871.
10. Caby MP, Lankar D, Vincendeau-Scherrer C, Raposo G, Bonnerot C, (2005) Exosomal-like vesicles are present in human blood plasma. Int Immunol 17: 879-887 10.1093/intimm/dxh267.
11. Ronquist G, (2012) Prostasomes are mediators of intercellular communication: From basic research to clinical implications. J Intern Med 271: 400-413 --10.1111/j.1365-2796.2011.02487.x; 10.1111/j.1365-2796.2011.02487.x.
12. Putz U, Howitt J, Doan A, Goh CP, Low LH, et al. (2012) The tumor suppressor PTEN is exported in exosomes and has phosphatase activity in recipient cells. Sci Signal 5: ra70 10.1126/scisignal.2003084.
13. Ronquist G, Nilsson BO, (2004) The janus-faced nature of prostasomes: Their pluripotency favours the normal reproductive process and malignant prostate growth. Prostate Cancer Prostatic Dis 7: 21-31 10.1038/sj. pcan.4500684.
14. Tavoosidana G, Ronquist G, Darmanis S, Yan J, Carlsson L, et al. (2011) Multiple recognition assay reveals prostasomes as promising plasma biomarkers for prostate cancer. Proc Natl Acad Sci U S A 108: 8809-8814 10.1073/pnas.1019330108.
15. Dziembor-Gryszkiewicz E, Fikus M, Kazimierczuk Z, Ostrowski W, (1978) Activity of human prostatic acid phosphatase toward purine 5′-phosphonucleosides. Bull Acad Pol Sci Biol 26: 815-821.
16. Tanaka M, Kishi Y, Takanezawa Y, Kakehi Y, Aoki J, et al. (2004) Prostatic acid phosphatase degrades lysophosphatidic acid in seminal plasma. FEBS Lett 571: 197-204 10.1016/j.febslet.2004.06.083.
17. Li HC, Chernoff J, Chen LB, Kirschonbaum A, (1984) A phosphotyrosyl-protein phosphatase activity associated with acid phosphatase from human prostate gland. Eur J Biochem 138: 45-51.
18. Vihko P, (1978) Characterization of the principal human prostatic acid phosphatase isoenzyme, purified by affinity chromatography and isoelectric focusing. part II. Clin Chem 24: 1783-1787.
19. Zylka MJ, Sowa NA, Taylor-Blake B, Twomey MA, Herrala A, et al. (2008) Prostatic acid phosphatase is an ectonucleotidase and suppresses pain by generating adenosine. Neuron 60: 111-122 10.1016/j.neuron.2008.08.024.
20. Saheki Y, De Camilli P, (2012) Synaptic vesicle endocytosis. Cold Spring Harb Perspect Biol 410.1101/cshperspect.a005645 10.1101/cshperspect.a005645; 10.1101/cshperspect.a005645.
21. Sowa NA, Street SE, Vihko P, Zylka MJ, (2010) Prostatic acid phosphatase reduces thermal sensitivity and chronic pain sensitization by depleting phosphatidylinositol 4,5-bisphosphate. J Neurosci 30: 10282-10293 -10.1523/JNEUROSCI.2162-10.2010.
22. Fasshauer D, Sutton RB, Brunger AT, Jahn R, (1998) Conserved structural features of the synaptic fusion complex: SNARE proteins reclassified as Q- and R-SNAREs. Proc Natl Acad Sci U S A 95: 15781-15786.
23. Deak F, Schoch S, Liu X, Sudhof TC, Kavalali ET, (2004) Synaptobrevin is essential for fast synaptic-vesicle endocytosis. Nat Cell Biol 6: 1102-1108 10.1038/ncb1185.
24. Pan PY, Tian JH, Sheng ZH, (2009) Snapin facilitates the synchronization of synaptic vesicle fusion. Neuron 61: 412-424 10.1016/j.neuron.2008.12.029.
25. Ilardi JM, Mochida S, Sheng ZH, (1999) Snapin: A SNARE-associated protein implicated in synaptic transmission. Nat Neurosci 2: 119-124 10.1038/5673.
26. Starcevic M, Dell'Angelica EC, (2004) Identification of snapin and three novel proteins (BLOS1, BLOS2, and BLOS3/reduced pigmentation) as subunits of biogenesis of lysosome-related organelles complex-1 (BLOC-1). J Biol Chem 279: 28393-28401 10.1074/jbc.M402513200.
27. Zhou B, Cai Q, Xie Y, Sheng ZH, (2012) Snapin recruits dynein to BDNF-TrkB signaling endosomes for retrograde axonal transport and is essential for dendrite growth of cortical neurons. Cell Rep 2: 42-51 10.1016/j.celrep.2012.06.010; 10.1016/j.celrep.2012.06.010.
28. Cai Q, Lu L, Tian JH, Zhu YB, Qiao H, et al. (2010) Snapin-regulated late endosomal transport is critical for efficient autophagy-lysosomal function in neurons. Neuron 68: 73-86 10.1016/j.neuron.2010.09.022; 10.1016/j.neuron.2010.09.022.
29. Song WJ, Seshadri M, Ashraf U, Mdluli T, Mondal P, et al. (2011) Snapin mediates incretin action and augments glucose-dependent insulin secretion. Cell Metab 13: 308-319 10.1016/j.cmet.2011.02.002; 10.1016/j.cmet.2011.02.002.
30. Sharma P, Schreiber-Agus N, (1999) Mouse models of prostate cancer. Oncogene 18: 5349-5355 10.1038/sj. onc.1203037.
31. Shappell SB, Thomas GV, Roberts RL, Herbert R, Ittmann MM, et al. (2004) Prostate pathology of genetically engineered mice: Definitions and classification. The consensus report from the bar harbor meeting of the mouse models of human cancer consortium prostate pathology committee. Cancer Res 64: 2270-2305.
32. Marker PC, Donjacour AA, Dahiya R, Cunha GR, (2003) Hormonal, cellular, and molecular control of prostatic development. Dev Biol 253: 165-174.
33. Vihko PT, Quintero I, Rönkö AE, Herrala A, Jäntti P, et al. (2005) Prostatic acid phosphatase (PAP) is PI (3) P-phosphatase and its inactivation leads to change of cell polarity and invasive prostate cancer. Proceedings of the AACR Abstract 5239: 96th Annual Meeting. Anaheim, CA, USA.
34. Kenworthy AK, (2001) Imaging protein-protein interactions using fluorescence resonance energy transfer microscopy. Methods 24: 289-296 10.1006/meth.2001.1189.
35. Sahlen G, Nilsson O, Larsson A, Carlsson L, Norlen BJ, et al. (2010) Secretions from seminal vesicles lack characteristic markers for prostasomes. Ups J Med Sci 115: 107-112 10.3109/03009730903366067; 10.3109/03009730903366067.
36. Xue L, Yang K, Newmark H, Lipkin M, (1997) Induced hyperproliferation in epithelial cells of mouse prostate by a western-style diet. Carcinogenesis 18: 995-999.
37. Roy-Burman P, Wu H, Powell WC, Hagenkord J, Cohen MB, (2004) Genetically defined mouse models that mimic natural aspects of human prostate cancer development. Endocr Relat Cancer 11: 225-254.
38. Carver BS, Tran J, Gopalan A, Chen Z, Shaikh S, et al. (2009) Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate. Nat Genet 41: 619-624 10.1038/ng.370.
39. Wang S, Gao J, Lei Q, Rozengurt N, Pritchard C, et al. (2003) Prostate-specific deletion of the murine PTEN tumor suppressor gene leads to metastatic prostate cancer. Cancer Cell 4: 209-221.
40. Svensson RU, Haverkamp JM, Thedens DR, Cohen MB, Ratliff TL, et al. (2011) Slow disease progression in a C57BL/6 pten-deficient mouse model of prostate cancer. Am J Pathol 179: 502-512 10.1016/j.ajpath.2011.03.014.
41. King HW, Michael MZ, Gleadle JM, (2012) Hypoxic enhancement of exosome release by breast cancer cells. BMC Cancer 12: 421 ---10.1186/1471-2407-12-421.
42. Record M, Subra C, Silvente-Poirot S, Poirot M, (2011) Exosomes as intercellular signalosomes and pharmacological effectors. Biochem Pharmacol 81: 1171-1182 10.1016/j.bcp.2011.02.011; 10.1016/j.bcp.2011.02.011.
43. Muthuswamy SK, Xue B (2012) Cell polarity as a regulator of cancer cell behavior plasticity. Annu Rev Cell Dev Biol. 10.1146/annurev-cellbio-092910-154244.
44. Wei S, Xu Y, Shi H, Wong SH, Han W, et al. (2010) EHD1 is a synaptic protein that modulates exocytosis through binding to snapin. Mol Cell Neurosci 45: 418-429 10.1016/j.mcn.2010.07.014.
45. Ruder C, Reimer T, Delgado-Martinez I, Hermosilla R, Engelsberg A, et al. (2005) EBAG9 adds a new layer of control on large dense-core vesicle exocytosis via interaction with snapin. Mol Biol Cell 16: 1245-1257 --10.1091/mbc.E04-09-0817.
46. Buxton P, Zhang XM, Walsh B, Sriratana A, Schenberg I, et al. (2003) Identification and characterization of snapin as a ubiquitously expressed SNARE-binding protein that interacts with SNAP23 in non-neuronal cells. Biochem J 375: 433-440 10.1042/BJ20030427.
47. Chheda MG, Ashery U, Thakur P, Rettig J, Sheng ZH, (2001) Phosphorylation of snapin by PKA modulates its interaction with the SNARE complex. Nat Cell Biol 3: 331-338 10.1038/35070000.
48. Golembiowska K, Dziubina A, (2004) Striatal adenosine A (2A) receptor blockade increases extracellular dopamine release following l-DOPA administration in intact and dopamine-denervated rats. Neuropharmacology 47: 414-426 10.1016/j.neuropharm.2004.04.018.
49. Uustare A, Reinart R, Rinken A, (2006) Modulation of dopamine D1 receptor signaling by adenosine A1 receptors in Sf9 cells requires expression of gi proteins. Neurosci Lett 406: 169-173 10.1016/j.neulet.2006.07.051.
50. Hein P, Rochais F, Hoffmann C, Dorsch S, Nikolaev VO, et al. (2006) Gs activation is time-limiting in initiating receptor-mediated signaling. J Biol Chem 281: 33345-33351 10.1074/jbc.M606713200.
51. Bonifacino JS, Traub LM, (2003) Signals for sorting of transmembrane proteins to endosomes and lysosomes. Annu Rev Biochem 72: 395-447 10.1146/annurev.biochem.72.121801.161800.